Polysubstance Use: Why Most Real Cases Are Mixed, and How Treatment Adapts
Plain, fact-first answers about how care works here. Want to talk to a person? Call (888) 464-2144.
- The Archangel Centers is a licensed outpatient addiction treatment provider.
- The Archangel Centers operates clinics in Tinton Falls, NJ and Charlotte, NC.
- Polysubstance use disorder is part of the outpatient continuum at The Archangel Centers.
- Medication-assisted treatment (MAT) includes Suboxone, Vivitrol, and Sublocade.
- The Archangel Centers works with most major commercial insurance plans with free benefits verification.
The phrase "alcohol use disorder" or "opioid use disorder" suggests a clean clinical picture: one substance, one diagnosis, one treatment plan. The reality at the door of most treatment programs is messier. Most people arriving for help are using more than one substance, often deliberately, often in patterns that interact in important clinical ways. Polysubstance use is not a separate diagnosis; it is the typical context within which substance use disorders show up. Treatment that ignores it produces predictable failures. Treatment that addresses it works.
This page covers the common combinations, why they matter clinically, and how The Archangel Centers handles them in the outpatient continuum.
Common polysubstance patterns
Opioids and benzodiazepines
The most clinically dangerous common combination, and the most common combination involved in fatal overdoses. Both depress respiration; combined, the depression is multiplicative, not additive. The FDA carries a black-box warning on this combination.
Clinical implications:
See opioid use disorder and benzodiazepine dependence for the individual substances; the treatment for the combination integrates both.
- Treatment plans usually stabilize the opioid use disorder first (with buprenorphine-based MAT), then carefully taper the benzodiazepine
- Coordinated medical detox at an accredited partner facility is often the right starting point
- Underlying anxiety conditions that drove benzodiazepine use need ongoing treatment with non-benzodiazepine medications (SSRIs, SNRIs, buspirone) and CBT
Stimulants and opioids
Increasingly common, both intentionally (the "speedball" pattern of combining heroin or fentanyl with cocaine or methamphetamine) and unintentionally (fentanyl-contaminated stimulant supply).
Clinical implications:
- The stimulant masks early signs of opioid respiratory depression; overdose risk is elevated
- MAT for the opioid component is essential; behavioral treatment for the stimulant component is the parallel work
- Carry naloxone, even when stimulants are the "primary" substance
Alcohol with sedatives or opioids
Alcohol combined with benzodiazepines or opioids amplifies respiratory depression. Alcohol combined with cocaine forms a toxic metabolite (cocaethylene) that is more cardiotoxic than either alone.
Clinical implications:
- Alcohol withdrawal in combination with benzodiazepine dependence requires careful inpatient detox management
- Alcohol use needs to be assessed and addressed even when the "main" substance is something else
- Naltrexone (Vivitrol) treats both alcohol and opioid use disorders
Cannabis with other substances
Cannabis use is so common in patients with other substance use disorders that it sometimes gets treated as background noise. Clinically, that is a mistake. Daily heavy cannabis use can:
Cannabis use disorder is real, and treating it as part of the broader plan often improves outcomes for the primary substance.
- Worsen anxiety, depression, and psychotic symptoms
- Reduce motivation and engagement in treatment
- Interfere with sleep architecture, which compounds the underlying mood and anxiety conditions
Nicotine
Tobacco and nicotine dependence is the most common substance use disorder in people with other SUDs, and the leading cause of death in people who otherwise recover from substance use disorders. We address it as part of the overall plan when the client is ready.
Why polysubstance matters for treatment planning
Different withdrawal profiles
Different substances have different withdrawal syndromes. A person dependent on alcohol, opioids, and benzodiazepines has three different withdrawal trajectories to manage, two of which (alcohol and benzo) can be medically dangerous. Detox planning has to address all three.
Medication interactions
MAT for opioid use disorder interacts with benzodiazepines, alcohol, and other CNS depressants. Decisions about timing, dose, and monitoring change when multiple substances are in play.
Co-occurring mental health
The underlying mental health picture in polysubstance use is usually more complex, not less. Depression, anxiety, PTSD, ADHD, and bipolar disorder all show up more frequently in polysubstance presentations. See the dual diagnosis.
Relapse triggers are more numerous
Each substance has its own trigger landscape (people, places, emotional states). Relapse prevention work has to address each, not just the primary.
How The Archangel Centers handles polysubstance use
Assessment that names everything
The intake battery (ASAM Criteria, LOCUS, PHQ-9, GAD-7, Columbia, biopsychosocial, nutrition, pain) captures the full substance and mental health picture. We treat what we find, not just the substance that brought the person to the call.
Coordinated medical stabilization where needed
For complex withdrawal pictures (alcohol plus benzodiazepines, opioids plus benzodiazepines), we coordinate placement at an accredited partner inpatient detox facility before the client steps into our outpatient continuum. See medical detox in Tinton Falls and medical detox in Charlotte.
Integrated outpatient continuum
The same Partial Care, IOP, and OP that treat single-substance presentations treat polysubstance presentations. The treatment plan is broader, but the structure is the same. See PHP at Tinton Falls and PHP at Charlotte.
MAT for the components where it applies
MAT (Suboxone, Sublocade, Vivitrol) for the opioid component; medical taper for the benzodiazepine component (often coordinated through inpatient detox); behavioral treatment as the primary mode for stimulants and cannabis. Methadone is not in our formulary.
Dual diagnosis as the default
We do not assume a single diagnosis. Treatment plans integrate mental health from day one.
Polysubstance overdose, what to do
- Always carry naloxone if any opioid is in the picture.
- Call 911. Polysubstance overdoses can be unpredictable.
- Administer naloxone if opioid involvement is suspected. Naloxone does not work on benzodiazepines, alcohol, or stimulants alone, but it will reverse the opioid component if one is present.
- Place the person on their side and stay with them until help arrives.
Frequently Asked Questions
My main problem is alcohol but I also smoke weed daily. Should I quit both?
Can I keep my benzo prescription while I treat my opioid use?
What if I am also drinking heavily?
Will I be tested for everything?
Is it harder to treat polysubstance use?
What about substance use that involves prescribed medications I still take?
Will treatment cost more if I have multiple substance use disorders?
How does The Archangel Centers decide which substance to address first?
Admissions are confidential and staffed 24/7 at (888) 464-2144. Or browse a specific clinic page for hours, address, and the full program.